Clinical experience with novel K+ binders: what are the opportunities and challenges?
Topic:
Treatment
Speaker:
Professor C. Linde (Stockholm, SE)
Professor A. Coats (Coventry, GB)
Professor M. Volterrani (Rome, IT)
Sponsored by AstraZeneca
Event:
Heart Failure 2019
Congress Presentation
About the speakers
Professor Cecilia Linde
Karolinska Institutet, Stockholm (Sweden)
53
presentations
2
followers
Professor Andrew Coats
University of Warwick, Coventry (United Kingdom of Great Britain & Northern Ireland)
109
presentations
19
followers
Professor Maurizio Volterrani
San Raffaele Pisana Hospital IRCCS, Rome (Italy)
18
presentations
6
followers
4 more presentations in this session
Chair's introduction - The hyperkalaemia challenge in heart failure: what is the role of novel agents?
Speaker: Professor A. Coats (Coventry, GB)
Hyperkalaemia: a barrier to optimal management of patients with heart failure?
Speaker: Professor A. Coats (Coventry, GB)
Solving the K+ challenge in heart failure: are novel K+ binders the answer?
Speaker: Professor M. Volterrani (Rome, IT)
Access the full session
The hyperkalaemia challenge in heart failure: what is the role of novel agents?
Speakers:
Professor C. Linde, Professor A. Coats, Professor M. Volterrani, Professor A. Coats, Professor C. Linde...
About the event
ESC 365 is supported by
